Cassava Sciences | PTIE - Ebitda





Ebitda Cambiamento Data
Abbott USD 2.43B 844M 2026-03
Amgen USD 5.14B 775M 2025-12
Biogen USD 649.7M 76.5M 2026-03
Cara Therapeutics USD -2.39M 3.16M 2025-03
Cassava Sciences USD -11.73M 33.44M 2025-09
Eisai JPY -335M 30.43B 2026-03
Eli Lilly USD 12.14B 4.26B 2025-12
Geron USD -21.29M 11.82M 2025-12
J&J USD 8.27B 1.08B 2026-03
Merck USD 6.3B 2.09B 2025-12
Novartis USD 6.48B 1.19B 2026-06
Novavax USD 19.36M 190.79M 2025-12
Pfizer USD 5.99B 5.23B 2026-03
Roche Holding CHF 13.43B 744M 2026-06